Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Conference News EuroPCR 2025

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Yael L. Maxwell

June 02, 2025

News Conference News ACC 2023

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Yael L. Maxwell

March 09, 2023

News Conference News TCT 2020

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Shelley Wood

October 17, 2020

News Daily News

采用第二代 DES 的双支架策略在治疗分叉病变时无劣势

Yael L. Maxwell

August 26, 2015

News Daily News

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

Yael L. Maxwell

August 26, 2015

News Daily News

La Estrategia de Doble Stent en Lesiones en Bifurcación con SLF de 2ª Generación No tiene Ninguna Desventaja

Yael L. Maxwell

August 26, 2015

News Daily News

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

July 10, 2014

News Daily News

HOST-ASSURE: Promus Element No es Inferior al Resolute en una Población de Pacientes No Seleccionados

July 10, 2014

News Daily News

HOST-ASSURE：在一般人群中，Promus Element不比Resolute差

July 10, 2014

Presentation TCT 2013

The Promus Element Everolimus-Eluting Stent: Design Considerations and Clinical Trial Results (from PLATINUM to HOST-ASSURE)

Presenter: Hyo-Soo Kim

October 28, 2013

Presentation ACC 2013

Randomized Comparison of PtCr-EES vs CoCr-ZES in All-Comers Receiving PCI: The HOST-ASSURE Randomized Trial

Presenter: Hyo-Soo Kim

March 08, 2013

News Conference News ACC 2013

Pair of Studies Show Positive Stent Results at ACC

Yael L. Maxwell

March 08, 2013

News Daily News

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Caitlin E. Cox

December 26, 2012

News Daily News

Equivalencia en el Mundo Real Confirmada de los Stents liberadores de Zotarolimus y Everolimus

Caitlin E. Cox

December 26, 2012

Presentation ACC 2012

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

Presenter: Hyo-Soo Kim

March 24, 2012

News Daily News

El Celecoxib Aumenta la Eficacia de los SLF a un determinado Coste Clínico

March 15, 2012

News Daily News

Celecoxib Enhances DES Efficacy, But at Clinical Cost

March 15, 2012

Presentation TCT 2012

Neointimal Hyperplasia and Peristent Vascular Remodeling after Implantation of Everolimus-eluting Stent versus Sirolimus-eluting Stent. Intravascular Ultrasound Results from...

Presenter: Young-Guk Ko, Dong-Ho Shin, Jung-Sun Kim, Byeong-Keuk Kim, Donghoon Choi, Myeong-Ki Hong, Hyeon-Cheol Gwon, Taehoon Ahn, In-Ho Chae, Jung-Han Yoon, Hyo-Soo Kim, Yangsoo Jang

January 03, 2012

News Daily News

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

October 17, 2011

News Daily News

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

January 09, 2011

Advertisement

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

采用第二代 DES 的双支架策略在治疗分叉病变时无劣势

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

La Estrategia de Doble Stent en Lesiones en Bifurcación con SLF de 2ª Generación No tiene Ninguna Desventaja

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

HOST-ASSURE: Promus Element No es Inferior al Resolute en una Población de Pacientes No Seleccionados

HOST-ASSURE：在一般人群中，Promus Element不比Resolute差

The Promus Element Everolimus-Eluting Stent: Design Considerations and Clinical Trial Results (from PLATINUM to HOST-ASSURE)

Randomized Comparison of PtCr-EES vs CoCr-ZES in All-Comers Receiving PCI: The HOST-ASSURE Randomized Trial

Pair of Studies Show Positive Stent Results at ACC

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Equivalencia en el Mundo Real Confirmada de los Stents liberadores de Zotarolimus y Everolimus

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

El Celecoxib Aumenta la Eficacia de los SLF a un determinado Coste Clínico

Celecoxib Enhances DES Efficacy, But at Clinical Cost

Neointimal Hyperplasia and Peristent Vascular Remodeling after Implantation of Everolimus-eluting Stent versus Sirolimus-eluting Stent. Intravascular Ultrasound Results from...

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content